<- Go Home

The Oncology Institute, Inc.

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Market Cap

$304.4M

Volume

1.7M

Cash and Equivalents

$33.6M

EBITDA

-$29.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$76.4M

Profit Margin

15.20%

52 Week High

$4.88

52 Week Low

$1.62

Dividend

N/A

Price / Book Value

-19.37

Price / Earnings

-5.66

Price / Tangible Book Value

-8.97

Enterprise Value

$374.6M

Enterprise Value / EBITDA

-20.07

Operating Income

-$36.1M

Return on Equity

999.19%

Return on Assets

-13.37

Cash and Short Term Investments

$33.6M

Debt

$103.8M

Equity

-$15.7M

Revenue

$502.7M

Unlevered FCF

-$12.3M

Sector

Health Care Providers and Services

Category

N/A

Company Stock Pitches